Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America as Represented By The Secretary of the Department of Health and Human”

379 pharma patents match "The United States of America as Represented By The Secretary of the Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 379
Index total 30,257
Page 5 / 16

Quick answer

This filtered view shows 379 pharmaceutical patents matching "The United States of America as Represented By The Secretary of the Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

379 results for “The United States of America as Represented By The Secretary of the Department of Health and Human” · 30,257 patents in full index Clear search

  1. US 8835378

    Multi-domain amphipathic helical peptides and methods of their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  2. US 8828717

    Framework residue substituted humanized COL-1 antibodies and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  3. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  4. US 8822192

    Human rotavirus vaccine strains and diagnostics

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  5. US 8809502

    Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  6. US 8778847

    Immunogenic peptides of influenza virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  7. US 8778671

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  8. US 8772238

    Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  9. US 8771706

    Anti-RSV immunogens and methods of immunization

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  10. US 8748114

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  11. US 8747863

    Vaccine for shigella

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  12. US 8748608

    4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  13. US 8741947

    Biologically active macrolides, compositions, and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  14. US 8741869

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  15. US 8735355

    Methods of use of fragments of secreted frizzled related protein, sFRP

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  16. US 8735407

    Purine derivatives as A3 adenosine receptor-selective agonists

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  17. US 8729053

    Nuclear factor kappa B pathway inhibitor composition and use of same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 20, 2014 · Expires May 15, 2034

    granted
  18. US 8716315

    Analogs of thalidomide as potential angiogenesis inhibitors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted
  19. US 8715689

    Chimeric west nile/dengue viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 6, 2014 · Expires May 1, 2034

    granted
  20. US 8703826

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted
  21. US 8703096

    Beta-amyloid PET imaging agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted
  22. US 8691501

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  23. US 8680046

    Inhibitors of viral integrase and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted
  24. US 8673629

    Recombinant Rift Valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted